CJ's Law: Mixed Drug Death, Cardiovascular Disease, and a Blanket Kratom Ban

Why it matters

CJ's Law uses a death officially ruled 'mixed drug intoxication including mitragynine' with contributory cardiovascular disease to justify banning all kratom products. The law does not distinguish natural leaf from the concentrated 7-OH products that federal regulators have specifically targeted.

The big picture

CJ's Law — named after a death the public campaign describes as 'kratom killed CJ' — is built on an autopsy that tells a more complicated story. The medical examiner listed multiple contributing factors. The proposed law collapses a mixed-drug death involving a compromised heart into a single-category prohibition.

Key findings

• Official cause of death: mixed drug intoxication including mitragynine — not 'kratom overdose.'
• Contributory: hypertensive cardiovascular disease. Manner: accident.
• Additional substances documented: amphetamine, bupropion, hydroxybupropion, diphenhydramine, meprobamate, THC, plus urine presumptive positives.
• Cardiovascular factors: biventricular cardiac hypertrophy, BMI 35, borderline diabetes, congestion and edema.
• The law does not distinguish natural leaf from extract, concentrated 7-OH, or adulterated products.
• Product form question: the official record does not isolate which kratom product was involved.
• Open Truth's position: a mixed-drug death with documented cardiac disease should not become a blanket botanical ban.

What they say

"A one-substance story does not match the panel." — Open Truth Project

Bottom line

The real risk factors — unregulated products, drug interactions, polypharmacy, missing warnings — call for product testing, labeling, age restrictions, and concentrated-product limits. CJ's Law, as written, addresses none of those specifically.